Utama › Kanser Hati (Karsinoma Hepatoselular) › California › San Francisco
Kajian klinikal Kanser Hati (Karsinoma Hepatoselular) di San Francisco, CA
14 kajian untuk Kanser Hati (Karsinoma Hepatoselular) sedang mencari peserta di lokasi dalam dan sekitar San Francisco (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of ZW251 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- UCSF Comprehensive Cancer Center, San Francisco
National Liver Cancer Screening Trial
Mengambil pesertaFasa 4
- University of California, San Francisco, San Francisco
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
Mengambil pesertaFasa 1
- UCSF Medical Center at Mount Zion, San Francisco
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Mengambil pesertaKajian pemerhatian
- Sutter Bay Hospitals, San Francisco
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Mengambil pesertaFasa 1/2
- UCSF Medical Center-Mission Bay, San Francisco
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial
Mengambil pesertaFasa 3
- California Pacific Medical Center-Pacific Campus, San Francisco
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
Mengambil peserta
- University of California, San Francisco, San Francisco
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
Mengambil pesertaFasa 1/2
- UCSF Benioff Children's Hospitals, San Francisco
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Mengambil pesertaFasa 2
- University of California San Francisco, San Francisco
Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular Carcinoma
Mengambil pesertaFasa 2
- University of California, San Francisco, San Francisco
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Mengambil pesertaKajian pemerhatian
- Massive Bio SYNERGY-AI site, San Francisco
A Multicenter Cancer Biospecimen Collection Study
Mengambil pesertaKajian pemerhatian
- Curebase, San Francisco
Kajian Kanser Hati (Karsinoma Hepatoselular) di bandar lain
- Houston, TX31 kajian
- New York City, NY24 kajian
- Dallas, TX19 kajian
- Los Angeles, CA19 kajian
- Boston, MA18 kajian
- Cleveland, OH18 kajian
- Chicago, IL16 kajian
- Philadelphia, PA16 kajian
- Pittsburgh, PA15 kajian
- Orange, CA14 kajian
- Jacksonville, FL14 kajian
- San Antonio, TX13 kajian
Kajian lain di San Francisco
- Kanser Prostat45 kajian
- Kanser Payudara43 kajian
- Kanser Paru-paru Bukan Sel Kecil36 kajian
- Kanser (semua jenis)35 kajian
- Kegagalan Jantung29 kajian
- Kanser Metastatik28 kajian
- Kanser Paru-paru22 kajian
- Melanoma22 kajian
- Kanser Pankreas20 kajian
- Kanser Ovari19 kajian
- Kanser Kolorektal18 kajian
- Penyakit Kardiovaskular18 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.